Drugs Made In America Acquisition Corp. Balance Sheet
Drugs Made In America Acquisition Corp.'s total assets for Q3 2025 were $237.63M, an increase of 1.03% from the previous quarter. DMAA total liabilities were $7.36M for the fiscal quarter, a 2.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.